Element Biosciences

Element Biosciences is a multi-disciplinary startup that innovates genetic analysis tools for research and diagnostic markets. Founded in 2017 by scientists Molly He, Michael Previte, and Matthew Kellinger, the company aims to democratize access to genomic sequencing and advanced biological tools. Their mission is to empower the scientific community, enhancing the pace of discovery and opening new possibilities in biology. The company offers several products, including the AVITI™ DNA benchtop sequencing platform, which launched in 2022. This platform utilizes avidite base chemistry to increase access to genomic sequencing across various industries, such as academia, biotech, and agriculture. The advanced AVITI24 platform provides enhanced data output and features a multiomics workflow that integrates RNA sequencing, protein, and cell morphology analysis without library preparation. Element Biosciences serves a global customer base in over 40 countries and has contributed to more than 400 publications, holding nearly 30 unique patents.